Amelioration of motor/sensory dysfunction and spasticity in a rat model of acute lumbar spinal cord injury by human neural stem cell transplantation

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Van Gorp, Sebastiaan ^a,b   Leerink, Marjolein ^a   Kakinohana, Osamu ^a   Platoshyn, Oleksandr ^a   Santucci, Camila ^a   Galik, Jan ^c,d   Joosten, Elbert A ^b   Hruska Plochan, Marian ^a,f,g   Goldberg, Danielle ^a   Marsala, Silvia ^a   Johe, Karl ^e   Ciacci, Joseph D ^a,h   Marsala, Martin ^a,c,i  

^a School of Medicine   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d P J AFÁRIK UNIVERSITY   (Slovakia)

^e Neuralstem Inc   (United States)

^f INSTITUTE OF ANIMAL PHYSIOLOGY AND GENETICS   (Czech Republic)

^g CHARLES UNIVERSITY   (Czech Republic)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ SANFORD CONSORTIUM FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Functional recovery; Human neural stem cells; Rat; Spinal cord injury; Spinal grafting

Indexed keywords

METHYLPREDNISOLONE ACETATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; FEMALE; GABAERGIC SYSTEM; GAIT; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; JOINT MOBILITY; LOCOMOTION; LUMBAR SPINE; MOTOR DYSFUNCTION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN FIELD TEST; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SENSORY DYSFUNCTION; SPASTICITY; SPINAL CORD COMPRESSION; ANIMAL; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GRAFT SURVIVAL; MOTOR ACTIVITY; MUSCLE SPASTICITY; NEURAL STEM CELL; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT; TRANSPLANTATION; XENOGRAFT;

ANIMALIA; RATTUS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MOTOR ACTIVITY; MUSCLE SPASTICITY; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; TACROLIMUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84878264271     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt209     Document Type: Article

References (82)

1. Degenerative and spontaneous regenerative processes after spinal cord injury. Hagg T, Oudega M, J Neurotrauma 2006 23 264 280 16629615
2. Gross morphological changes of the spinal cord immediately after surgical decompression in a large animal model of traumatic spinal cord injury. Jones CF, Cripton PA, Kwon BK, Spine 2012 37 890 E899 10.1097/BRS.0b013e3182553d1d 22433504
3. Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair. Oudega M, Cell Tissue Res 2012 349 269 288 10.1007/s00441-012-1440-6 22592628
4. Steroids for acute spinal cord injury. Bracken MB, Cochrane Database Syst Rev 2012 1 CD001046
5. The cellular inflammatory response in human spinal cords after injury. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC, Brain 2006 129 3249 3269 10.1093/brain/awl296 17071951
6. Repertoire of microglial and macrophage responses after spinal cord injury. David S, Kroner A, Nat Rev Neurosci 2011 12 388 399 10.1038/nrn3053 21673720
7. Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury. Ankeny DP, Popovich PG, Neuroscience 2009 158 1112 1121 10.1016/j.neuroscience.2008.07.001 18674593
8. Growth factors and combinatorial therapies for CNS regeneration. Lu P, Tuszynski MH, Exp Neurol 2008 209 313 320 10.1016/j.expneurol.2007.08.004 17927983
9. Stem cell therapies for spinal cord injury. Sahni V, Kessler JA, Nat Rev Neurol 2010 6 363 372 10.1038/nrneurol.2010.73 20551948
10. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Llado J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD, Mol Cell Neurosci 2004 27 322 331 10.1016/j.mcn.2004.07.010 15519246
11. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. Bonner JF, Connors TM, Silverman WF, Kowalski DP, Lemay MA, Fischer I, J Neurosci 2011 31 4675 4686 10.1523/JNEUROSCI.4130-10. 2011 21430166
12. Neuronal progenitor transplantation and respiratory outcomes following upper cervical spinal cord injury in adult rats. White TE, Lane MA, Sandhu MS, O'Steen BE, Fuller DD, Reier PJ, Exp Neurol 2010 225 231 236 10.1016/j.expneurol.2010.06.006 20599981
13. Embryonic brain precursors transplanted into kainate lesioned rat spinal cord. Magnuson DS, Zhang YP, Cao QL, Han Y, Burke DA, Whittemore SR, Neuroreport 2001 12 1015 1019 10.1097/00001756-200104170-00030 11303737
14. Early graft of neural precursors in spinal cord compression reduces glial cyst and improves function. Boido M, Garbossa D, Vercelli A, J Neurosurg Spine 2011 15 97 106 10.3171/2011.1.SPINE10607 21456892
15. Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Erceg S, Ronaghi M, Oria M, Rosello MG, Arago MA, Lopez MG, Radojevic I, Moreno-Manzano V, Rodriguez-Jimenez FJ, Bhattacharya SS, Cordoba J, Stojkovic M, Stem Cells 2010 28 1541 1549 10.1002/stem.489 20665739
16. Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice. Hendricks WA, Pak ES, Owensby JP, Menta KJ, Glazova M, Moretto J, Hollis S, Brewer KL, Murashov AK, Mol Med 2006 12 34 46 16838066
17. Stem cell therapy for the spinal cord. Donnelly EM, Lamanna J, Boulis NM, Stem Cell Res Ther 2012 3 24 10.1186/scrt115 22776143
18. Neural tissue engineering using embryonic and induced pluripotent stem cells. Willerth SM, Stem Cell Res Ther 2011 2 17 10.1186/scrt58 21539726
19. Isolation of neural stem cells from neural tissues using the neurosphere technique. Ferrari D, Binda E, De Filippis L, Vescovi AL, Curr Protoc Stem Cell Biol 2010 2 6 21049474
20. A new method for the rapid and long term growth of human neural precursor cells. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T, Caldwell MA, J Neurosci Methods 1998 85 141 152 10.1016/S0165-0270(98)00126- 5 9874150
21. In vitro expansion of a multipotent population of human neural progenitor cells. Carpenter MK, Cui X, Hu ZY, Jackson J, Sherman S, Seiger A, Wahlberg LU, Exp Neurol 1999 158 265 278 10.1006/exnr.1999.7098 10415135
22. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Yan J, Xu L, Welsh AM, Chen D, Hazel T, Johe K, Koliatsos VE, Stem Cells 2006 24 1976 1985 10.1634/stemcells.2005-0518 16644922
23. Direct isolation of human central nervous system stem cells. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL, Proc Natl Acad Sci U S A 2000 97 14720 14725 10.1073/pnas.97.26.14720 11121071
24. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Vescovi AL, Parati EA, Gritti A, Poulin P, Ferrario M, Wanke E, Frolichsthal-Schoeller P, Cova L, Arcellana-Panlilio M, Colombo A, Galli R, Exp Neurol 1999 156 71 83 10.1006/exnr.1998.6998 10192778
25. Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. Guo X, Johe K, Molnar P, Davis H, Hickman J, J Tissue Eng Regen Med 2010 4 181 193 10.1002/term.223 19950213
26. Clinical Trials with 'huCNS-SC', NLM database search results http://www.clinicaltrials.gov/ct2/results?term=hucns-sc
27. A Phase l, Open-label, First in Human, Feasibility and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis-Identifier: NCT01348451 http://www.clinicaltrial. gov/ct2/show/NCT01348451
28. Jacobs Y, Selden N, Al-Uzri A, Koch T, Vogel H, Huhn S, Uchida N, Dalma-Weiszhausz D, Tsukamoto A, Steiner R, Long-term survival and migration of allogeneic human central nervous system stem cells following intracerebral transplantation in neuronal ceroid lipofuscinosis Toronto, ON, Canada: ISSCR 2011 Annual Meeting 2011
29. Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cells. Cizkova D, Kakinohana O, Kucharova K, Marsala S, Johe K, Hazel T, Hefferan MP, Marsala M, Neuroscience 2007 147 546 560 10.1016/j.neuroscience.2007.02.065 17524565
30. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation. Hefferan MP, Galik J, Kakinohana O, Sekerkova G, Santucci C, Marsala S, Navarro R, Hruska-Plochan M, Johe K, Feldman E, Cleveland DW, Marsala M, PLoS One 2012 7 42614 10.1371/journal.pone.0042614 22916141
31. Translational stem cell therapy for amyotrophic lateral sclerosis. Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL, Nat Rev Neurol 2011 8 172 176 10.1038/nrneurol.2011.191 22158518
32. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES, Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH, Cell 2012 150 1264 1273 10.1016/j.cell.2012.08.020 22980985
33. Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS. Hefferan MP, Johe K, Hazel T, Feldman EL, Lunn JS, Marsala M, Cell Transplant 2011 20 1153 1161 10.3727/ 096368910X564553 21669047
34. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Johe KK, Hazel TG, Muller T, Dugich-Djordjevic MM, McKay RD, Genes Dev 1996 10 3129 3140 10.1101/gad.10.24.3129 8985182
35. A sensitive and reliable locomotor rating scale for open field testing in rats. Basso DM, Beattie MS, Bresnahan JC, J Neurotrauma 1995 12 1 21 10.1089/neu.1995.12.1 7783230
36. Limitations in transplantation of astroglia-biomatrix bridges to stimulate corticospinal axon regrowth across large spinal lesion gaps. Deumens R, Koopmans GC, Honig WM, Maquet V, Jerome R, Steinbusch HW, Joosten EA, Neurosci Lett 2006 400 208 212 10.1016/j.neulet.2006.02.050 16530957
37. Objective measures of motor dysfunction after compression spinal cord injury in adult rats: correlations with locomotor rating scores. Semler J, Wellmann K, Wirth F, Stein G, Angelova S, Ashrafi M, Schempf G, Ankerne J, Ozsoy O, Ozsoy U, Schönau E, Angelov DN, Irintchev A, J Neurotrauma 2011 28 1247 1258 10.1089/neu.2010.1737 21428717
38. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. Apostolova I, Irintchev A, Schachner M, J Neurosci 2006 26 7849 7859 10.1523/JNEUROSCI.1526- 06.2006 16870730
39. Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter. Marsala M, Hefferan MP, Kakinohana O, Nakamura S, Marsala J, Tomori Z, J Neurotrauma 2005 22 1348 1361 10.1089/neu.2005.22.1348 16305323
40. Estimating efficacy and drug ED50's using von Frey thresholds: impact of weber's law and log transformation. Mills C, Leblond D, Joshi S, Zhu C, Hsieh G, Jacobson P, Meyer M, Decker M, J Pain 2012 13 519 523 10.1016/j.jpain.2012.02. 009 22543045
41. Chronic spinal compression model in minipigs: a systematic behavioral, qualitative, and quantitative neuropathological study. Navarro R, Juhas S, Keshavarzi S, Juhasova J, Motlik J, Johe K, Marsala S, Scadeng M, Lazar P, Tomori Z, Schulteis G, Beattie M, Ciacci JD, Marsala M, J Neurotrauma 2012 29 499 513 10.1089/neu.2011.2076 22029501
42. The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. Koopmans GC, Deumens R, Honig WM, Hamers FP, Steinbusch HW, Joosten EA, J Neurotrauma 2005 22 214 225 10.1089/neu.2005.22.214 15716628
43. Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: colocalization of GAP-43 and CGRP. Ondarza AB, Ye Z, Hulsebosch CE, Exp Neurol 2003 184 373 380 10.1016/j.expneurol.2003.07.002 14637107
44. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. Hains BC, Waxman SG, J Neurosci 2006 26 4308 4317 10.1523/JNEUROSCI.0003-06.2006 16624951
45. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat. Taira Y, Marsala M, Stroke 1996 27 1850 1858 10.1161/01.STR.27.10.1850 8841344
46. Transient spinal ischemia in the rat: characterization of behavioral and histopathological consequences as a function of the duration of aortic occlusion. Marsala M, Yaksh TL, J Cereb Blood Flow Metab 1994 14 526 535 10.1038/jcbfm.1994.65 8163596
47. Motoneuron loss associated with chronic locomotion impairments after spinal cord contusion in the rat. Collazos-Castro JE, Soto VM, Gutierrez-Davila M, Nieto-Sampedro M, J Neurotrauma 2005 22 544 558 10.1089/neu.2005.22.544 15892600
48. Functional consequences of lumbar spinal cord contusion injuries in the adult rat. Magnuson DS, Lovett R, Coffee C, Gray R, Han Y, Zhang YP, Burke DA, J Neurotrauma 2005 22 529 543 10.1089/neu.2005.22.529 15892599
49. Velocity-dependent ankle torque in rats after contusion injury of the midthoracic spinal cord: time course. Bose P, Parmer R, Thompson FJ, J Neurotrauma 2002 19 1231 1249 10.1089/08977150260338029 12427331
50. Observations on the pathology of human spinal cord injury: a review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM, Adv Neurol 1993 59 75 89 8420126
51. Spasticity after spinal cord injury. Adams MM, Hicks AL, Spinal Cord 2005 43 577 586 10.1038/sj.sc.3101757 15838527
52. Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord. Ek CJ, Habgood MD, Callaway JK, Dennis R, Dziegielewska KM, Johansson PA, Potter A, Wheaton B, Saunders NR, PLoS One 2010 5 12021 10.1371/journal.pone.0012021 20711496
53. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Bramlett HM, Dietrich WD, Prog Brain Res 2007 161 125 141 17618974
54. Obliteration of a posttraumatic spinal cord cyst with solid human embryonic spinal cord grafts: first clinical attempt. Falci S, Holtz A, Akesson E, Azizi M, Ertzgaard P, Hultling C, Kjaeldgaard A, Levi R, Ringden O, Westgren M, Lammertse D, Seiger A, J Neurotrauma 1997 14 875 884 10.1089/neu.1997.14.875 9421458
55. Feasibility and safety of neural tissue transplantation in patients with syringomyelia. Wirth ED 3rd, Reier PJ, Fessler RG, Thompson FJ, Uthman B, Behrman A, Beard J, Vierck CJ, Anderson DK, J Neurotrauma 2001 18 911 929 10.1089/089771501750451839 11565603
56. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Hawryluk GW, Mothe A, Wang J, Wang S, Tator C, Fehlings MG, Stem Cells Dev 2012 21 2222 2238 10.1089/scd.2011.0596 22085254
57. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. Yan J, Welsh AM, Bora SH, Snyder EY, Koliatsos VE, J Comp Neurol 2004 480 101 114 10.1002/cne.20344 15514921
58. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Lu P, Jones LL, Snyder EY, Tuszynski MH, Exp Neurol 2003 181 115 129 10.1016/S0014-4886(03)00037-2 12781986
59. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. Yan J, Xu L, Welsh AM, Hatfield G, Hazel T, Johe K, Koliatsos VE, PLoS Med 2007 4 39 10.1371/journal.pmed.0040039 17298165
60. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE, Transplantation 2006 82 865 875 17038899
61. Neural stem/progenitor cells transplanted to the hypoglossal nucleus integrates with the host CNS in adult rats and promotes motor neuron survival. Fagerlund M, Estrada CP, Jaff N, Svensson M, Brundin L, Cell Transplant 2012 21 739 747 10.3727/096368911X612459 22182695
62. Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. Rota Nodari L, Ferrari D, Giani F, Bossi M, Rodriguez-Menendez V, Tredici G, Delia D, Vescovi AL, De Filippis L, PLoS One 2010 5 14035 10.1371/journal.pone.0014035 21124963
63. Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Lepore AC, Neuhuber B, Connors TM, Han SS, Liu Y, Daniels MP, Rao MS, Fischer I, Neuroscience 2006 142 287 304 10.1016/j.neuroscience.2005.12.067 17120358
64. Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Cummings BJ, Uchida N, Tamaki SJ, Anderson AJ, Neurol Res 2006 28 474 481 10.1179/016164106X115116 16808875
65. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L, Nat Neurosci 2005 8 346 353 10.1038/nn1405 15711542
66. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. Mitsui T, Shumsky JS, Lepore AC, Murray M, Fischer I, J Neurosci 2005 25 9624 9636 10.1523/JNEUROSCI.2175-05.2005 16237167
67. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW, Nat Med 1999 5 1410 1412 10.1038/70986 10581084
68. Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Alexanian AR, Svendsen CN, Crowe MJ, Kurpad SN, Cytotherapy 2011 13 61 68 10.3109/14653249.2010.510504 20735167
69. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. Davies JE, Proschel C, Zhang N, Noble M, Mayer-Proschel M, Davies SJ, J Biol 2008 7 24 10.1186/jbiol85 18803859
70. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN, Exp Neurol 2006 201 335 348 10.1016/j.expneurol.2006.04.035 16839548
71. Astrocytes derived from glial-restricted precursors promote spinal cord repair. Davies JE, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies SJ, J Biol 2006 5 7 10.1186/jbiol35 16643674
72. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. Jin Y, Neuhuber B, Singh A, Bouyer J, Lepore A, Bonner J, Himes T, Campanelli JT, Fischer I, J Neurotrauma 2011 28 579 594 10.1089/neu.2010.1626 21222572
73. Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior. Baastrup C, Maersk-Moller CC, Nyengaard JR, Jensen TS, Finnerup NB, Pain 2010 151 670 679 10.1016/j.pain.2010.08.024 20863621
74. Numb rats walk-a behavioural and fMRI comparison of mild and moderate spinal cord injury. Hofstetter CP, Schweinhardt P, Klason T, Olson L, Spenger C, Eur J Neurosci 2003 18 3061 3068 10.1111/j.1460-9568.2003.03062.x 14656301
75. Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat. Anseloni VC, Gold MS, J Pain 2008 9 732 738 10.1016/j.jpain.2008.03.004 18467182
76. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De Koninck Y, Nature 2003 424 938 942 10.1038/nature01868 12931188
77. Intrathecal baclofen therapy over 10 years. Rawlins PK, J Neurosci Nurs 2004 36 322 327 10.1097/01376517-200412000-00005 15673207
78. Development of GABA-sensitive spasticity and rigidity in rats after transient spinal cord ischemia: a qualitative and quantitative electrophysiological and histopathological study. Kakinohana O, Hefferan MP, Nakamura S, Kakinohana M, Galik J, Tomori Z, Marsala J, Yaksh TL, Marsala M, Neuroscience 2006 141 1569 1583 10.1016/j.neuroscience.2006.04.083 16797137
79. Combinational spinal GAD65 gene delivery and systemic GABA-mimetic treatment for modulation of spasticity. Kakinohana O, Hefferan MP, Miyanohara A, Nejime T, Marsala S, Juhas S, Juhasova J, Motlik J, Kucharova K, Strnadel J, Platoshyn O, Lazar P, Galik J, Vinay L, Marsala M, PLoS One 2012 7 30561 10.1371/journal.pone.0030561 22291989
80. Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Liu J, Wolfe D, Hao S, Huang S, Glorioso JC, Mata M, Fink DJ, Mol Ther 2004 10 57 66 10.1016/j.ymthe.2004.04.017 15233942
81. Post-traumatic syringomyelia: a review of the literature. Biyani A, el Masry WS, Paraplegia 1994 32 723 731 10.1038/sc.1994.117 7885714
82. Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs. Usvald D, Vodicka P, Hlucilova J, Prochazka R, Motlik J, Kuchorova K, Johe K, Marsala S, Scadeng M, Kakinohana O, Navarro R, Santa M, Hefferan MP, Yaksh TL, Marsala M, Cell Transplant 2010 19 1103 1122 10.3727/096368910X503406 20412634